Literature DB >> 31834590

Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?

Timothé Ménard1, Björn Koneswarakantha2, Donato Rolo3, Yves Barmaz2, Leszek Popko2, Rich Bowling4.   

Abstract

Entities:  

Year:  2020        PMID： 31834590     DOI： 10.1007/s40264-019-00894-3

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  2 in total

Review 1.  Machine Learning in Causal Inference: Application in Pharmacovigilance.

Authors:  Yiqing Zhao; Yue Yu; Hanyin Wang; Yikuan Li; Yu Deng; Guoqian Jiang; Yuan Luo
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

2.  Harnessing the Power of Quality Assurance Data: Can We Use Statistical Modeling for Quality Risk Assessment of Clinical Trials?

Authors:  Björn Koneswarakantha; Timothé Ménard; Donato Rolo; Yves Barmaz; Rich Bowling
Journal:  Ther Innov Regul Sci       Date:  2020-03-30       Impact factor: 1.778
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.